Menu
GeneBe

rs201107889

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001349253.2(SCN11A):c.5067C>G(p.Phe1689Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00013 in 1,614,084 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 0 hom. )

Consequence

SCN11A
NM_001349253.2 missense

Scores

1
8
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:2

Conservation

PhyloP100: 0.380
Variant links:
Genes affected
SCN11A (HGNC:10583): (sodium voltage-gated channel alpha subunit 11) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family, and is highly expressed in nociceptive neurons of dorsal root ganglia and trigeminal ganglia. It mediates brain-derived neurotrophic factor-evoked membrane depolarization and is a major effector of peripheral inflammatory pain hypersensitivity. Mutations in this gene have been associated with hereditary sensory and autonomic neuropathy type VII and familial episodic pain syndrome-3. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03214398).
BP6
Variant 3-38847003-G-C is Benign according to our data. Variant chr3-38847003-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 474743.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000309 (47/152200) while in subpopulation AMR AF= 0.00242 (37/15292). AF 95% confidence interval is 0.0018. There are 0 homozygotes in gnomad4. There are 29 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd at 47 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SCN11ANM_001349253.2 linkuse as main transcriptc.5067C>G p.Phe1689Leu missense_variant 30/30 ENST00000302328.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SCN11AENST00000302328.9 linkuse as main transcriptc.5067C>G p.Phe1689Leu missense_variant 30/305 NM_001349253.2 A2Q9UI33-1

Frequencies

GnomAD3 genomes
AF:
0.000309
AC:
47
AN:
152082
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00242
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000223
AC:
56
AN:
250896
Hom.:
0
AF XY:
0.000199
AC XY:
27
AN XY:
135582
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.00278
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000353
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.000111
AC:
163
AN:
1461884
Hom.:
0
Cov.:
33
AF XY:
0.000120
AC XY:
87
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.000581
Gnomad4 ASJ exome
AF:
0.00371
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000135
Gnomad4 OTH exome
AF:
0.000397
GnomAD4 genome
AF:
0.000309
AC:
47
AN:
152200
Hom.:
0
Cov.:
32
AF XY:
0.000390
AC XY:
29
AN XY:
74412
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00242
Gnomad4 ASJ
AF:
0.00259
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000268
Hom.:
0
Bravo
AF:
0.000280
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000173
AC:
21
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicApr 19, 2021- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxDec 02, 2020Identified as heterozygous in a patient with painful peripheral neuropathy who did not have other pathogenic variants in SCN9A or SCN10A (Huang et al., 2014); Published functional studies demonstrate a damaging effect with increased activity of Nav1.9 (Zhou et al., 2017); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 30557356, 26243570, 26462871, 29213238, 24776970, 30046661) -
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria providedliterature onlyInherited Neuropathy Consortium-- -
Hereditary motor neuron disease Uncertain:1
Uncertain significance, no assertion criteria providedprovider interpretationInherited Neuropathy Consortium-- -
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 03, 2021This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Hereditary sensory and autonomic neuropathy type 7;C3809899:Familial episodic pain syndrome with predominantly lower limb involvement Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeJan 18, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.95
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.13
Cadd
Benign
18
Dann
Uncertain
1.0
DEOGEN2
Uncertain
0.51
D;.
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.080
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.63
T;T
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.032
T;T
MetaSVM
Uncertain
0.019
D
MutationAssessor
Benign
0.81
L;.
MutationTaster
Benign
0.95
D;D;D
PrimateAI
Uncertain
0.76
T
PROVEAN
Uncertain
-2.8
D;N
REVEL
Uncertain
0.37
Sift
Benign
0.19
T;T
Sift4G
Benign
1.0
T;T
Polyphen
0.21
B;.
Vest4
0.35
MutPred
0.43
Loss of helix (P = 0.2271);.;
MVP
0.87
MPC
0.67
ClinPred
0.060
T
GERP RS
4.1
Varity_R
0.31
gMVP
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201107889; hg19: chr3-38888494; API